Cdt Equity Inc 's Cash & cash equivalent grew by 600 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Cdt Equity Inc 's Quick Ratio to 0.03, Quick Ratio remained below Cdt Equity Inc average.

Within Major Pharmaceutical Preparations industry 493 other companies have achieved higher Quick Ratio than Cdt Equity Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 3662 to 5013.

Explain Quick Ratio?
How much Cash & cash equivalents CDT�s has?
What are CDT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CDT Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	875.8 %	1130.02 %	19.36 %	-79.98 %	-72.15 %
Y / Y Cash & cash equivalent Change	-78.99 %	-95.31 %	172.38 %	2425 %	669.52 %
Quick Ratio MRQ	0.03	0	0.12	1.6	1.39
CDT's Total Ranking	# 5013	# 3662	# 1606	# 1534	#
Seq. Current Liabilities Change	7.93 %	68.77 %	434.61 %	0.21 %	36.04 %
Seq. Cash & cash equivalent Change	600 %	-93.37 %	-60.68 %	15.19 %	56.43 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 494
Healthcare Sector	# 1001
Overall Market	# 5013

Quick Ratio Statistics
High	Average	Low
12.3	1.62	0
(Mar 31 2022)		(Mar 31 2026)

Financial Statements
Cdt Equity Inc 's Current Liabilities	$ 23 Millions	Visit CDT's Balance sheet
Cdt Equity Inc 's Cash & cash equivalent	$ 1 Millions	Visit CDT's Balance sheet
Source of CDT's Sales		Visit CDT's Sales by Geography

Cumulative Cdt Equity Inc 's Quick Ratio

CDT's Quick Ratio for the trailling 12 Months

CDT Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	124.06 %	18.67 %	-50.38 %	-42.54 %	18.27 %
Y / Y Cash & cash equivalent TTM Growth	-0.34 %	168.55 %	262.35 %	48.02 %	-59.28 %
Quick Ratio TTM	0.1	0.22	0.56	0.57	0.23
Total Ranking TTM	# 4745	# 3127	# 2972	# 2769	#
Seq. Current Liabilities TTM Growth	53.4 %	102.62 %	12.02 %	-35.65 %	-18.75 %
Seq. Cash & cash equivalent TTM Growth	-29.98 %	-18.78 %	9.69 %	59.76 %	88.68 %

Quick ratio ranking by company, industry and sector >> Back to CDT Financial Strength Comparisons >> Go to Compare CDT Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $23.35 millions, cumulative Quick Ratio decreased to 0.1 below the Cdt Equity Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 490 other companies have achieved higher Quick Ratio than Cdt Equity Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3127 to 4745.

Explain Quick Ratio?
How much Cash & cash equivalents CDT�s has?
What are CDT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 491
Healthcare Sector	# 1009
Within the Market	# 4745

trailing twelve months Quick Ratio Statistics
High	Average	Low
3.55	0.91	0.07
(Sep 30 2022)		(Dec 31 2024)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Processa Pharmaceuticals Inc	0.08	$ 0.196 Millions	$ 2.387 Millions
Cv Sciences Inc	0.05	$ 0.266 Millions	$ 4.943 Millions
Citius Pharmaceuticals Inc	0.05	$ 17.008 Millions	$ 333.952 Millions
Sunshine Biopharma Inc	0.05	$ 0.281 Millions	$ 5.619 Millions
Hcw Biologics Inc	0.04	$ 0.741 Millions	$ 18.648 Millions
China Pharma Holdings Inc	0.04	$ 0.305 Millions	$ 7.682 Millions
Bioxytran Inc	0.03	$ 0.177 Millions	$ 5.275 Millions
Cdt Equity Inc	0.03	$ 0.700 Millions	$ 23.351 Millions
Shuttle Pharmaceuticals Holdings Inc	0.03	$ 0.102 Millions	$ 3.481 Millions
Northwest Biotherapeutics Inc	0.01	$ 0.595 Millions	$ 42.982 Millions
Oncotelic Therapeutics Inc	0.01	$ 0.186 Millions	$ 17.907 Millions
Os Therapies Incorporated	0.01	$ 0.205 Millions	$ 20.653 Millions
The Greater Cannabis Company Inc	0.01	$ 0.000 Millions	$ 0.012 Millions
Chemocentryx Inc.	0.01	$ 1.253 Millions	$ 139.868 Millions
NIKA PHARMACEUTICALS, INC	0.01	$ 0.003 Millions	$ 0.341 Millions
Evofem Biosciences Inc	0.01	$ 0.714 Millions	$ 88.615 Millions

Date modified: 2026-09-08T17:03:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.